These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 32695641)

  • 21. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
    Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
    CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular MR imaging in cardio-oncology.
    Tamene AM; Masri C; Konety SH
    Magn Reson Imaging Clin N Am; 2015 Feb; 23(1):105-16. PubMed ID: 25476679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic Imaging in Cardio-oncology.
    Tong D; Zaha VG
    J Cardiovasc Transl Res; 2020 Jun; 13(3):357-366. PubMed ID: 31696405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Precision Cardio-Oncology.
    Dreyfuss AD; Bravo PE; Koumenis C; Ky B
    J Nucl Med; 2019 Apr; 60(4):443-450. PubMed ID: 30655328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardio-oncology: the role of advanced echocardiography in cancer patients.
    Venneri L; Zoppellaro G; Khattar RS
    Expert Rev Cardiovasc Ther; 2018 Apr; 16(4):249-258. PubMed ID: 29457984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and Management of Cancer Treatment-Related Cardiac Dysfunction and Heart Failure in Children.
    Hegazy M; Ghaleb S; Das BB
    Children (Basel); 2023 Jan; 10(1):. PubMed ID: 36670699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Update on the Role of Cardiac Magnetic Resonance Imaging in Cancer Patients.
    Pons-Riverola A; Ghosh AK
    Curr Cardiol Rep; 2022 Dec; 24(12):2139-2147. PubMed ID: 36342641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.
    Parent S; Pituskin E; Paterson DI
    Can J Cardiol; 2016 Jul; 32(7):847-51. PubMed ID: 27343743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management.
    Domercant J; Polin N; Jahangir E
    Ochsner J; 2016; 16(3):250-6. PubMed ID: 27660573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organization and implementation of a cardio-oncology program.
    Fiuza M; Ribeiro L; Magalhães A; Sousa AR; Nobre Menezes M; Jorge M; Costa L; Pinto FJ
    Rev Port Cardiol; 2016 Sep; 35(9):485-94. PubMed ID: 27503589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
    Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
    BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of cardiovascular magnetic resonance in early detection and treatment of cardiac dysfunction in oncology patients.
    Vallabhaneni S; Zhang KW; Alvarez-Cardona JA; Mitchell JD; Steen H; Woodard PK; Lenihan DJ
    Int J Cardiovasc Imaging; 2021 Oct; 37(10):3003-3017. PubMed ID: 33982196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Cardiac Imaging Modalities for the Early Detection of Cardiotoxicity Due to Anticancer Therapies.
    López-Fernández T; Thavendiranathan P
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):487-495. PubMed ID: 28189542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac magnetic resonance assessment of cardiac involvement in autoimmune diseases.
    Gulhane A; Ordovas K
    Front Cardiovasc Med; 2023; 10():1215907. PubMed ID: 37808881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology.
    Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G
    J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e45-e54. PubMed ID: 27755242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardio-oncology Part II: the monitoring, prevention, detection and treatment of chemotherapeutic cardiac toxicity.
    O'Hare M; Murphy K; Mookadam F; Sharma A; Lee H
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):519-27. PubMed ID: 25864865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiotoxicity of Contemporary Breast Cancer Treatments.
    Lee Chuy K; Yu AF
    Curr Treat Options Oncol; 2019 May; 20(6):51. PubMed ID: 31073788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units].
    Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G
    Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview.
    Foulkes S; Claessen G; Howden EJ; Daly RM; Fraser SF; La Gerche A
    Front Cardiovasc Med; 2020; 7():32. PubMed ID: 32211421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.